Integrated BioPharma Inc (INBP) stock
INBPOTCPharmaceutical PreparationsFiscal year ends June 30
$0.18+0.00 (0.00%)
Close on Oct 19, 2026Market cap $5.59MP/E –Yield –
Integrated BioPharma total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Integrated BioPharma's total debt was $18.00K at Mar 31, 2024. For fiscal 2023 it was $49.00K, down 42.4% from the year before. Over ten years it grew -37.9% a year on average. The highest annual figure on record is $6.19M in fiscal 2012.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Jun 30, 2023 | $49.00K | -42.4% |
| FY2022 | Jun 30, 2022 | $85.00K | -94.2% |
| FY2021 | Jun 30, 2021 | $1.46M | -65.8% |
| FY2020 | Jun 30, 2020 | $4.26M | +13.0% |
| FY2019 | Jun 30, 2019 | $3.77M | -14.3% |
| FY2018 | Jun 30, 2018 | $4.40M | -18.0% |
| FY2017 | Jun 30, 2017 | $5.36M | -12.6% |
| FY2016 | Jun 30, 2016 | $6.14M | +31.7% |
| FY2015 | Jun 30, 2015 | $4.66M | -5.8% |
| FY2014 | Jun 30, 2014 | $4.95M | -14.1% |
| FY2013 | Jun 30, 2013 | $5.76M | -7.1% |
| FY2012 | Jun 30, 2012 | $6.19M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $18.00K | -77.8% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $49.00K | -42.4% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $60.00K | – |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $70.00K | +483.3% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $81.00K | -40.4% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $85.00K | -94.2% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $0 | -100.0% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $12.00K | -99.6% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $136.00K | -96.1% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $1.46M | -65.8% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $3.21M | +14.8% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $3.33M | +9.0% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $3.49M | +8.0% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $4.26M | +13.0% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $2.80M | -30.1% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $3.05M | -23.4% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $3.23M | -22.5% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $3.77M | -14.3% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $4.00M | -12.6% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $3.98M | -16.2% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $4.17M | -13.1% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $4.40M | -18.0% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $4.58M | -18.8% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $4.75M | -15.9% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $4.80M | -17.7% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $5.36M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $5.64M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $5.65M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $5.83M | – |
See a number that looks wrong?